mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
pitstop2 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.6 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.6 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.6 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |